Clinical development of adoptive immunotherapy with CD19-specific chimeric antigen receptor-modified T cells in patients with B-cell malignancy.
2016
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI